Free Trial

Will Soghikian Analyst Performance

Analyst at Leerink Partners

Will Soghikian is a stock analyst at Leerink Partners in the healthcare sector, covering 6 publicly traded companies. Over the past year, Will Soghikian has issued 6 stock ratings, including buy and hold recommendations. While full access to Will Soghikian's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Will Soghikian's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
6 Last 0 Years
Buy Recommendations
83.33% 5 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.3%5 ratings
Hold16.7%1 ratings
Sell0.0%0 ratings

Out of 6 total stock ratings issued by Will Soghikian at Leerink Partners, the majority (83.3%) have been Buy recommendations, followed by 16.7% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
6 companies

Will Soghikian, an analyst at Leerink Partners, currently covers 6 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
6 companies
100.0%

Will Soghikian of Leerink Partners specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
6 companies
100.0%

Will Soghikian's Ratings History at Leerink Partners

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Equillium, Inc. stock logo
EQ
Equillium
10/12/2026Initiated Coverage$1.41$6.00Outperform
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
10/12/2026Initiated Coverage$0.87$4.00Outperform
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
10/12/2026Initiated Coverage$8.34$40.00Outperform
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
10/12/2026Initiated Coverage$29.88$34.00Market Perform
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
10/12/2026Initiated Coverage$41.17$130.00Outperform
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
10/12/2026Reiterated Rating$143.73$190.00Outperform